GoodRx Holdings, Inc. 8-K

What Happened
GoodRx Holdings, Inc. (GDRX) filed a Form 8-K on Feb. 27, 2026, reporting that director Dipanjan Deb resigned from the company’s Board of Directors effective February 26, 2026. The filing states Mr. Deb indicated his resignation was not due to any disagreement with the company or its management.

Key Details

• Event reported under Item 5.02 (Departure of Directors or Certain Officers).
• Resignation effective date: February 26, 2026.
• Resigning director: Dipanjan Deb.
• Filing signed by Christopher McGinnis, Chief Financial Officer & Treasurer, on February 27, 2026.
• The 8-K notes the resignation was not due to any disagreement over the company’s operations, policies or practices; no replacement or board changes were disclosed in the filing.

Why It Matters
Board departures can affect corporate governance and investor perception. This filing informs shareholders of a change in the company’s board composition and confirms the departure is not tied to a dispute with management. Investors should watch for subsequent disclosures about any appointment to fill the vacancy or changes to the board structure.